BBIQ

Overview

BBIQ is a imidazoquinoline compound and a potent and selectively toll-like receptor 7 ( TLR7 ) agonist with an EC 50 of 59.1 nM for human TLR7 . BBIQ is a powerful vaccine adjuvant that enhances innate immune responses.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Toll-like Receptor (TLR)

Product Information

• Catalog No.: HY-111582
• CAS No.: 1229024-57-0
• Molecular Formula: C21H22N4
• Molecular Weight: 330.43
• Purity: 99.81%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 1.67 mg/mL (5.05 mM); Clear solution
• Availability: In-stock

Source

Original product source